Health and Labor Inspection Body of Armenia has warned citizens about a counterfeit batch of the medication Perjeta and advised people not to use it.
According to an official statement, the information was received on May 11, 2026, from the Scientific Center of Drug and Medical Technology Expertise. The notice stated that F. Hoffmann-La Roche reported a counterfeit case involving Perjeta (pertuzumab) concentrate solution for infusion, 30 mg/ml, 14 ml glass vial.
Authorities specified that the counterfeit concerns batch number 7796 of the medication.
Citizens are urged to carefully check medication packaging and avoid using products from the affected series. Officials also recommend contacting healthcare providers or pharmacies if there are any doubts regarding the authenticity of the medicine.
